Rhenman & Partners Asset Management Ab Staar Surgical CO Transaction History

Rhenman & Partners Asset Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$38.07 - $52.25 $2.47 Million - $3.4 Million	65,000 New	65,000 $3.09 Million
Q2 2018 Jul 20, 2018	SELL	$13.95 - $32.65 $343,979 - $805,083	-24,658 Closed	0 $0
Q1 2018 Apr 11, 2018	SELL	$14.35 - $16.5 $740,431 - $851,367	-51,598 Reduced 67.66%	24,658 $365,000
Q4 2017 Jan 19, 2018	SELL	$12.45 - $17.4 $171,112 - $239,145	-13,744 Reduced 15.27%	76,256 $1.18 Million
Q3 2017 Oct 13, 2017	BUY	$10.25 - $12.8 $922,500 - $1.15 Million	90,000	90,000 $1.12 Million

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.